openPR Logo
Press release

How will the Growth Unfold for Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market Leaders: Pfizer, Inc., Valeant Pharmaceuticals Inc., Novartis AG, Bayer AG, Sanofi S.A., GlaxoSmithKline plc.

05-30-2019 04:22 PM CET | Health & Medicine

Press release from: Future Market Insights

How will the Growth Unfold for Benign Prostatic Hyperplasia

The approximately US$ 25 Bn market for benign prostatic hyperplasia prostate treatment is likely to expand at 4.6% CAGR during 2018-2028, according to a recent research report of Future Market Insights (FMI). The report has envisaged steady growth prospects for the revenue of global benign prostatic hyperplasia prostate treatment market through 2028.

The World Population Prospects’ data (2017) projected that the number of individuals aged 60 years and above will double by 2050, and triple by 2100. With such a high pace estimated for the growth of population aged 60 years and above, it is more likely that the prevalence of aging related health conditions will also increase at a considerable pace in the years to come. A high prevalence rate of benign prostatic hyperplasia (BPH) in men, the demand for improved and more effective treatment options continues to increase at a high rate.

Competition Analysis

The competitive landscape of benign prostatic hyperplasia prostate treatment market involves some of the industry behemoths, posing strong competition facing other smaller players. The report covers Pfizer, Inc., Valeant Pharmaceuticals Inc., Novartis AG, Bayer AG, Sanofi S.A., GlaxoSmithKline plc., Bristol-Myers Squibb and Company, Teva Pharmaceutical Industries Ltd, Mylan N.V., Merck & Co., Cardinal Health Inc., and Eli Lilly and Company among others.

Request to Download a Sample Copy of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1664

Alpha-blockers & Drugs for Lower UTIs Remain Pivotal in Benign Prostatic Hyperplasia Prostate Treatment

The drug treatment has been vital in treating benign prostatic hyperplasia conditions and lower UTIs, which has been attributed to widespread availability of drug-based benign prostatic hyperplasia prostate treatment. This factor, in particular, will play an instrumental role in driving the growth of the benign prostatic hyperplasia prostate treatment market during the forecast period. Drugs will remain the first choice of treatment for benign prostatic hyperplasia.

Benign prostatic hyperplasia increases the risk of other disorders as well. The most common disorder caused due to benign prostatic hyperplasia is lower UTI (urinary tract infection) for which, Alpha-blockers constitute the first line of treatment. However, other drugs are also available in the market, which offer relief from the benign prostatic hyperplasia symptoms. Other drugs include alpha reductase inhibitors, phosphodiesterase-5 (PDE-5) inhibitors, muscarinic receptor antagonists, and combination drugs.

Demand for Benign Prostatic Hyperplasia Prostate Treatment Higher in Developed Regions, Patient Pool Expanding Steadily in Developing Markets

Owing to significantly growing prevalence of benign prostatic hyperplasia in North American men, benign prostatic hyperplasia prostate treatment market is expected to witness strong growth within the region, followed by Europe.

Extensive availability of benign prostatic hyperplasia prostate treatments, increasing clinical trials, improving R&D scenario, higher healthcare spending, and favorable government initiatives will continue to assist the growth of the benign prostatic hyperplasia prostate treatment market in developed regions.

On the other side, Asia Pacific’s benign prostatic hyperplasia prostate treatment market is foreseen to witness significant growth, owing to steadily expanding patient pool due in the region.

UroLift System to Revolutionize the Competitive Landscape of Benign Prostatic Hyperplasia Prostate Treatment Market

Teleflex Incorporated’s NeoTract recently launched UroLift® System as a highly effective, least invasive option for benign prostatic hyperplasia prostate treatment. The UroLift® System is permanently implanted via a transurethral outpatient procedure and predominantly relieves prostate obstruction, which is one of the primary symptoms of benign prostatic hyperplasia. The company has also declared insurance coverage for UroLift® System. While the coverage is being provided by Humana, it is most likely to improve awareness about increasing availability and broadening access of minimally invasive treatment methods in urological conditions such as benign prostatic hyperplasia. This in turn will encourage adoption of UroLift® System among patients seeking effective benign prostatic hyperplasia prostate treatment.

Need More Detailed Information about Methodology @ https://www.futuremarketinsights.com/askus/rep-gb-1664

A majority of patients with enlarged prostate continue to perceive medication and surgery as the only available treatment alternatives. However, an increasing number of physician recommendations is advocating the use of The UroLift® System as it eliminates side effects associated with other conventional options of benign prostatic hyperplasia prostate treatment.

Benign Prostatic Hyperplasia Bph And Prostate Treatment Market Reports - Table of Contents
1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. Technology Roadmap

1.4. FMI Analysis and Recommendations

2. Market Introduction

2.1. Market Introduction

2.2. Market Taxonomy

2.3. Market Definition

2.4. Inclusions and Exclusions

3. Benign Prostatic Hyperplasia Prostate Treatment Market Opportunity Analysis

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

4. Market Background

4.1. Market Dynamics

4.1.1. Drivers

4.1.2. Restraints

4.1.3. Key Trends

5. Key Inclusions

5.1. Pipeline Analysis

5.2. Prevalence and Treatment Seeking Population Analysis

6. Global Economic Outlook

6.1. Gross Domestic Product by Region & Country, 2006 – 2021

7. Global Benign Prostatic Hyperplasia Prostate Treatment Market Analysis 2013–2017 and Forecast 2018–2028, By Region

7.1. Introduction / Key Findings

7.2. Historical Market Size (US$ Mn) Trend Analysis by Region, 2013–2017

7.2.1. North America

7.2.2. Latin America

7.2.3. Europe

7.2.4. South Asia

7.2.5. East Asia

7.2.6. Oceania

7.2.7. The Middle East and Africa

7.2.8. Emerging Countries

7.3. Market Size (US$ Mn) Forecast By Region, 2018–2028

7.4. Market Attractiveness Analysis by Region

8. Global Benign Prostatic Hyperplasia Prostate Treatment Market Analysis 2013–2017 and Forecast 2018–2028, By Treatment Type

8.1. Introduction

8.2. Historical Market Size (US$ Mn) Trend Analysis by Treatment Type, 2013–2017

8.2.1. Drugs

8.2.1.1. Alpha Blockers

8.2.1.2. 5-alpha Reductase Inhibitors

8.2.1.3. Phosphodiesterase-5 (PDE-5) Inhibitors

8.2.1.4. Muscarinic Receptor Antagonist (MRA)

8.2.1.5. Combination Drug

8.2.2. Device

8.2.2.1. Prostatic Stents

8.2.2.2. Suture Base Implant Systems

8.2.2.3. Transurethral RF Thermal Therapy Devices

8.3. Market Size (US$ Mn) Forecast By Treatment Type, 2018–2028

8.4. Market Attractiveness Analysis by Treatment Type

Request to Browse Report Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-1664

About Us

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.

FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Contact Us

U.S. Office

616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989,

United States

T: +1-347-918-3531

F: +1-845-579-5705

Email: sales@futuremarketinsights.com

Blog: http://keepfacts.com/

Web: https://www.futuremarketinsights.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release How will the Growth Unfold for Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market Leaders: Pfizer, Inc., Valeant Pharmaceuticals Inc., Novartis AG, Bayer AG, Sanofi S.A., GlaxoSmithKline plc. here

News-ID: 1759832 • Views: 505

More Releases from Future Market Insights

How Changing Dynamics of Cable Testing Market are Reflecting on Growth Strategie …
Global Cable Testing Market: Introduction The cost of the substitution of cables that are concealed is very high. Faults in the cable, bending, kinking, and crushing, are not always visible, which has created the requirement for cable testing. Thus, cable testing helps check the cable functionality, cable quality, and cable conformity. Several times, cable testing by visual inspection is an effective way of identifying the actual problem before it causes any
How Transformative Trends in Self-Organising Network Market are Molding Strategi …
Self-Organising Network: Introduction With accelerated advancements and increasing complexities in the radio network technologies, such as those utilised for the development of LTE and 5G networks, which are used for planning, management, configuration, healing and optimisation, are required to be automated to facilitate efficiency. At present, suppliers are offering self-organising networks that possess the ability to offer optimum performance. Self-organising networks are use cases that perform network governance, including network planning,
Mining Vehicle AC Kits Market: Exploring the Impact of Trends on Strategies of K …
Mining Vehicle AC Kits Market: Introduction Cabin space in mining equipment has become more sophisticated in the recent past. The installation of mining vehicle AC kits has evolved from an optional feature to a necessary feature. Mining equipment manufacturers have made advancements in technology related to efficiency, performance and cost of air conditioning systems in order to make them affordable and economical to enable low-budget and compact installations without compromising on
Key Factors to Fuel Growth of the Talent Acquisition & Staffing Technology and S …
With the growing importance of recruiting and retaining top talent effectively and efficiently, smart hiring processes are the need of the hour. It is about time organisations move beyond merely scrutinising resumes. Salaries and benefits are important factors, but adopting ways that would make candidates an important part of the hiring process will attract the best talent. Studies reveal that due to discrepancies in existing Applicant Tracking Systems (ATS), hiring

All 5 Releases


More Releases for Treatment

Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview: The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025. Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,
Treatment of Patellofemoral Problems
The first line of treatment of patellofemoral problems focuses on reducing the inflammation in the knee. This can be achieved with rest and non-steroidal anti-inflammatory medication (NSAIDs) like Ibuprofen. Physical therapy may be advised for patients in the early stages of treatment. The therapy therapist may involves icing, massage, and/or ultrasound to prevent pain and swelling. Your surgeon or physical therapist may also recommend orthopedic bracing or taping for your
Anti-Snoring Treatment Market
Snoring is the vibration of respiratory structures which results in sound while sleeping. It is a sleeping disorder caused due to monotonous narrowing and collapsing of the upper airway. Snoring have various adverse effects on health include coronary artery disease, systemic hypertension, atrial fibrillation, and stroke. Snoring is one of the factors of sleep deprivation, which may be further caused due to throat weakness, mis-positioned jaw, obesity, and obstruction in
Acne Vulgaris Treatment Market
Acne vulgaris is a common skin disease characterized by blackheads, whiteheads, papules, and pustules on the face, neck, back, and chest. It is commonly observed in adolescent population, however, can also affect adults. Depending on its severity, acne may be segmented into mild, moderate or severe. It is caused due to excess oil produced in sebaceous glands under skin, which becomes plugged and inflated. Female patient with polycystic ovarian syndrome
Water Treatment Equipment Market
Water Treatment Equipment refers to the equipment used in the industrial water treatment. It includes Pre-treatment non-membrane, Pre-treatment membrane, ultrapure water, AD/EDI systems polishing, Inorganic WW treatment, Organic WW treatment, etc. The scope of the Report: This report focuses on the Water Treatment Equipment in the United States market, to split the market based on manufacturers, states, type and application. Sample Report Request: https://www.reportsandmarkets.com/sample-request/united-states-water-treatment-equipment-market-to-2022-1622845 Market Segment by Type, covers Pre-treatment non-membrane, Pre-treatment membrane, Ultrapure
Rheumatoid Arthritis Treatment Market
Rheumatoid arthritis (RA) is the most common autoimmune arthritis affecting more than 1.3 million U.S. citizens (American College of Rheumatology). More surprising is to know that around 75% of this affected population is women. Affecting the joints at any age, rheumatoid arthritis needs to be addressed early to avoid expensive joint replacement surgery. While it can affect any joint, small joints in hand and feet tend to be affected the